AU2025203019A1 — Ophthalmic Compositions Containing A Nitric Oxide Releasing Prostamide
Assigned to Nicox SA · Expires 2025-05-15 · 1y expired
What this patent protects
OPHTHALMIC COMPOSITIONS CONTAINING A NITRIC OXIDE RELEASING PROSTAMIDE The present invention provides aqueous ophthalmic compositions in the form of solution 5 comprising hexanoic acid, 6-(nitrooxy)-, (1S,2E)-3-[(1R,2R,3S,5R)-2-[(2Z)-7 (ethylamino)-7-oxo-2-hepten-1-yl]-3,5-dih…
USPTO Abstract
OPHTHALMIC COMPOSITIONS CONTAINING A NITRIC OXIDE RELEASING PROSTAMIDE The present invention provides aqueous ophthalmic compositions in the form of solution 5 comprising hexanoic acid, 6-(nitrooxy)-, (1S,2E)-3-[(1R,2R,3S,5R)-2-[(2Z)-7 (ethylamino)-7-oxo-2-hepten-1-yl]-3,5-dihydroxycyclopentyl]-1-(2-phenylethyl)-2 propen-l-yl ester and macrogol 15 hydroxystearate as the only solubilizing agent, and a method for their preparation.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.